PRAD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3
Lanlin Hu,Mingxin Liu,Bo Tang,Xurui Li,Huasheng Xu,Huani Wang,Dandan Wang,Sijia Liu,Chuan Xu
DOI: https://doi.org/10.1038/s41417-024-00829-w
IF: 5.854
2024-09-20
Cancer Gene Therapy
Abstract:Par6α encoded by PARD6A is a member of the PAR6 family and is reported to promote cancer initiation and progression. PARD6A is frequently upregulated in different types of cancers, but its regulatory role in lung cancer progression is yet to be established. In this study, we analyzed the PARD6A expression in biopsies from lung adenocarcinoma (LUAD) patients, and the survival probability using LUAD tissue microarray (TMA) and online datasets from TCGA and GEO. We conducted in vitro and in vivo assays to assess the role of PARD6A in regulating lung cancer progression, including proliferation, wound healing, transwell, RNA-seq, and subcutaneous tumor mice models. Our findings revealed that PARD6A is highly expressed in cancer tissues from LUAD patients and is associated with poor prognosis in LUAD patients. In vitro assays showed that PARD6A promoted cell proliferation, migration, and invasion. The transcriptome sequencing identified Serpina3 as one of the key downstream molecules of PARD6A . Ectopic expression of Serpina3 rescued impaired proliferation, migration, and invasion in PARD6A -knocking down H1299 cells, whereas silencing Serpina3 impeded enhanced proliferation, migration, and invasion in PARD6A -overexpressing H1975 cells. Our findings suggest that PARD6A promotes lung cancer progression by inducing Serpina3, which may be a promising therapeutic target.
oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology